Z-1675-2021 Class II Ongoing
FDA device recall Z-1675-2021 was initiated by Roche Diagnostics Operations, Inc. on Apr 26, 2021 and is designated Class II. Reason for recall: Roche received several complaints regarding increased control recovery and discrepant elevated results for the Iron Gen.2 (IRON2) assay on the cobas c311, 501, and 502 analyzers and on the COBAS… The recall status is ongoing. Affected quantity: 20,468 kits.
Recall details
- Product Type
- Devices
- Report Date
- Jun 2, 2021
- Initiation Date
- Apr 26, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 20,468 kits
Product description
Reason for recall
Distribution pattern
US Nationwide distribution in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, GU, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1675-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026